UroToday.com (@urotoday) 's Twitter Profile
UroToday.com

@urotoday

Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology

ID: 21319494

calendar_today19-02-2009 17:36:50

118,118K Tweet

28,28K Takipçi

6,6K Takip Edilen

UroToday.com (@urotoday) 's Twitter Profile Photo
UroToday.com
@urotoday

2 years ago

#NEMIO, a randomized phase I-II trial: Durvalumab +/- tremelimumab in combination with dose-dense MVAC as neoadjuvant treatment in patients with muscle-invasive bladder carcinoma. Presented by Constance Thibault Hôpital européen Georges-Pompidou AP-HP. #ESMO23 coverage by Rashid K. Sayyid > bit.ly/471gbmI

#NEMIO, a randomized phase I-II trial: Durvalumab +/- tremelimumab in combination with dose-dense MVAC as neoadjuvant treatment in patients with muscle-invasive bladder carcinoma. Presented by <a href="/laconss/">Constance Thibault</a> <a href="/HopitalPompidou/">Hôpital européen Georges-Pompidou AP-HP</a>. #ESMO23 coverage by <a href="/RKSayyid/">Rashid K. Sayyid</a> &gt; bit.ly/471gbmI